Share iSpecimen Expands Into AI-Powered Drug Discovery and Disease Trend Monitoring With Acquisition of Foldlab AI Products

Newsfile Corp · ISPC · November 5, 2026

iSpecimen Expands Into AI-Powered Drug Discovery and Disease Trend Monitoring With Acquisition of Foldlab AI Products

Stocks To Buy Now app

Get the app for more

Explore stock news, insights and company research.

Get the app →
Source: Newsfile Corp ↗